ABN virtual meeting 2020
ABN virtual meeting 2020 aims to promote excellent standards of care and champion high-quality education and world-class research in neurology and multiple sclerosis in the UK.
ABN 2020 took place in a virtual setting from 17 September 2020 to 12 November 2020. Roche data for the OCREVUS®▼(ocrelizumab) study MuSicalE and a market research on patients disease education are presented in two e-posters (prescribing information for Great Britain can be found here; prescribing information for Northern Ireland can be found here):
- Multiple Sclerosis Patient Perspectives: Disease Education and Communication Needs
- Ocrelizumab real-world effectiveness in patients with relapsing and primary progressive multiple sclerosis: MuSicalE baseline data
M-GB-00003249
Date of preaparation: April 2021